Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 56
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Vet Pathol ; 49(5): 760-5, 2012 Sep.
Article in English | MEDLINE | ID: mdl-21825314

ABSTRACT

The c-kit receptor is responsible for transmission of promigration signals to melanocytes; its downregulation may be involved in malignant progression of human melanocytic neoplasms. Expression of this receptor has not been examined in normal or neoplastic melanocytes from dogs. In this study, 14 benign dermal and 61 malignant mucosal melanocytic tumors were examined for c-kit (KIT) expression. Sites of the mucosal melanomas were gingiva (not further specified; n = 30), buccal gingiva (n = 6), soft palate (n = 4), hard palate (n = 5), tongue (n = 7), lip (n = 6), and conjunctiva (n = 3). Melan A was expressed in all 14 dermal melanocytomas and in 59 of 61 (96.7%) tumors from oral or conjunctival mucosa, confirming melanocytic origin. C-kit receptor expression was strong and diffuse throughout the cytoplasm in all 14 dermal melanocytomas and was identified in basilar mucosal melanocytes over submucosal neoplasms (27 of 61, 44.3%), junctional (neoplastic) melanocytes (17 of 61, 27.9%), and, less commonly, neoplastic melanocytes of the subepithelial tumors (6 of 61, 9.8%). KIT expression anywhere within the resected melanomas correlated with significantly longer survival. These results suggest that c-kit receptor expression may be altered in canine melanomas and may have potential as a prognostic indicator for mucosal melanomas.


Subject(s)
Biomarkers, Tumor/metabolism , Conjunctival Neoplasms/veterinary , Dog Diseases/metabolism , Melanoma/veterinary , Mouth Neoplasms/veterinary , Proto-Oncogene Proteins c-kit/metabolism , Animals , Conjunctival Neoplasms/metabolism , Conjunctival Neoplasms/pathology , Disease Progression , Dog Diseases/mortality , Dog Diseases/pathology , Dogs , Female , Gene Expression Regulation, Neoplastic , Immunohistochemistry/veterinary , MART-1 Antigen/metabolism , Male , Melanocytes/metabolism , Melanocytes/pathology , Melanoma/metabolism , Melanoma/pathology , Mouth Neoplasms/metabolism , Mouth Neoplasms/pathology , Prognosis , Receptor Protein-Tyrosine Kinases/metabolism , S100 Proteins/metabolism , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , Skin Neoplasms/veterinary , Survival Analysis
2.
Vet Pathol ; 48(3): 698-705, 2011 May.
Article in English | MEDLINE | ID: mdl-20876911

ABSTRACT

To comprehensively evaluate the occurrence of renal lesions in a variety of nondomestic felids, necropsy cases from 1978 to 2008 were reviewed from a municipal zoo and a large cat sanctuary for those in which the kidneys were examined histologically. Seventy exotic felids were identified (25 tigers, 18 lions, 6 cougars, 5 leopards, 3 snow leopards, 3 clouded leopards, 3 Canadian lynx, 2 ocelots, 2 bobcats, 2 cheetahs, 1 jaguar), and their histologic renal lesions were evaluated and compared. The most common lesion was tubulointerstitial nephritis (TIN); 36 of 70 (51%) cats were affected to some degree. Lymphocytic interstitial nephritis was the most common lesion in the tigers (9 of 25, 36%) and was rarely seen in other species. Although the renal pelvis was not available for all cats, 28 of 47 (60%) had some degree of lymphocytic pyelitis. There was no significant association between the presence of pyelitis and that of TIN. Only 1 cat had pyelonephritis. Renal papillary necrosis was present in 13 of 70 (19%) cats and was significantly associated with historical nonsteroidal anti-inflammatory drug treatment (odds ratio, 7.1; 95% confidence interval, 1.9 to 26.8). Only 1 cat (lion) had amyloid accumulation, and it was restricted to the corticomedullary junction. Primary glomerular lesions were absent in all cats. Intraepithelial pigment was identified in many of the cats but was not correlated with severity of TIN. Despite several previous reports describing primary glomerular disease or renal amyloidosis in exotic felids, these lesions were rare to absent in this population.


Subject(s)
Felidae , Kidney Diseases/veterinary , Animals , Animals, Zoo , Kidney/pathology , Kidney Diseases/pathology , Retrospective Studies
3.
Vet Pathol ; 47(6): 1071-5, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20817893

ABSTRACT

Thirty-two 4-month-old to 19-year-old female miniature pet pigs were spayed. Uterine lesions were present in all except 8 pigs. The 24 remaining pigs had diffuse cystic endometrial hyperplasia, of which 14 had smooth muscle tumors, including leiomyomas and leiomyosarcomas, in the uterus or broad ligament. Nodular endometrial lesions-including adenocarcinomas, adenomas, and/or adenomyosis-were present in 10 pigs, 3 of which had concurrent smooth muscle tumors. Pyometra was present in 3 pigs. In uterine sections with cystic endometrial hyperplasia, adenomyosis, or adenomas, approximately 70% of epithelial nuclei expressed estrogen receptor and progesterone receptor immunohistochemically; in adenocarcinomas, expression was 20%. Regardless of malignancy, more than 50% of nuclei in smooth muscle tumors expressed estrogen receptor and progesterone receptor. Aging was associated with the development of uterine lesions in miniature pet pigs.


Subject(s)
Swine Diseases/pathology , Swine, Miniature/anatomy & histology , Uterine Diseases/veterinary , Adenocarcinoma/pathology , Adenocarcinoma/veterinary , Adenoma/pathology , Adenoma/veterinary , Animals , Broad Ligament/pathology , Endometrial Hyperplasia/pathology , Endometrial Hyperplasia/veterinary , Endometrium/pathology , Estrogens/blood , Female , Leiomyoma/pathology , Leiomyoma/veterinary , Leiomyosarcoma/pathology , Leiomyosarcoma/veterinary , Progesterone/blood , Pyometra/pathology , Pyometra/veterinary , Swine , Swine Diseases/blood , Uterine Diseases/blood , Uterine Diseases/pathology , Uterine Neoplasms/pathology , Uterine Neoplasms/veterinary , Uterus/pathology
4.
Vet Pathol ; 46(5): 916-27, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19429997

ABSTRACT

Submissions to the University of Tennessee pathology service from June 1999 to June 2008 were searched for feline cases of tumors involving the eyelids or nictitans. Forty-three tumors were identified. The average age at diagnosis was 10.4 years. Significantly more males than females had eyelid tumors. There were 12 squamous cell carcinomas (SCCs), 11 mast cell tumors (MCTs), 6 hemangiosarcomas (HSAs), 4 adenocarcinomas (ACAs), 3 peripheral nerve sheath tumors (PNSTs), 3 lymphomas, 3 apocrine hidrocystomas (AHCs), and 2 hemangiomas. Cats with MCTs were significantly younger than cats with all other tumor types combined. In contrast, cats with SCCs were significantly older than cats with other tumor types. The HSAs and SCCs were significantly more likely than other tumors to occur in nonpigmented areas. The MCTs, HSAs, AHCs, and hemangiomas did not recur after surgical excision. In contrast, the lymphomas, ACAs, SCCs, and PNSTs frequently recurred and/or resulted in death or euthanasia of the cat. The SCCs were significantly more likely to recur than the MCTs. The average survival time for cats with SCCs was 7.4 months. Although eyelid MCTs have been reported in cats, the prevalence in this study is much higher than previously described.


Subject(s)
Cat Diseases/pathology , Eyelid Neoplasms/veterinary , Adenocarcinoma/epidemiology , Adenocarcinoma/pathology , Adenocarcinoma/veterinary , Animals , Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/veterinary , Cat Diseases/epidemiology , Cats , Eyelid Neoplasms/epidemiology , Eyelid Neoplasms/pathology , Female , Hemangiosarcoma/epidemiology , Hemangiosarcoma/pathology , Hemangiosarcoma/veterinary , Hidrocystoma/epidemiology , Hidrocystoma/pathology , Hidrocystoma/veterinary , Immunohistochemistry/veterinary , Lymphoma/epidemiology , Lymphoma/pathology , Lymphoma/veterinary , Male , Mastocytosis/epidemiology , Mastocytosis/pathology , Nerve Sheath Neoplasms/epidemiology , Nerve Sheath Neoplasms/pathology , Nerve Sheath Neoplasms/veterinary , Retrospective Studies
5.
J Comp Pathol ; 136(4): 231-9, 2007 May.
Article in English | MEDLINE | ID: mdl-17399734

ABSTRACT

The aim of this study was to characterize the pathology and clinical outcome of the subcutaneous variant of canine mast cell tumour. Fifty-three cases satisfying the inclusion criteria were selected from the pathology archive of the College of Veterinary Medicine, University of Tennessee. Referring veterinarians provided information on outcome. These dogs had a median age of 9 years (range 3-17 years). After characterizing tumours histologically, nuclear expression of proliferating cell nuclear antigen (PCNA) and Ki67 (MIB-1 clone) was determined immunohistochemically and mast cell origin was confirmed with c-Kit staining. Counts of argyrophilic nucleolar organizer regions (AgNOR) were determined by silver staining. Nuclear labelling was counted in 100 tumour cells. Margins were recorded as incomplete in 66% of dogs, and metastases occurred in 6% of dogs. The estimated minimum mean survival time from date of diagnosis was 1199 days, ranging from 55 to >1780 days. The median scores from immunohistochemical labelling were PCNA 0.05 and Ki67 0.03 per 100 tumour cells. The median score for AgNOR staining was 1.25 per 100 tumour cells. The patterns of c-Kit expression included membranous labelling in 20 tumours, stippled cytoplasmic labelling in 23 tumours and diffuse cytoplasmic labelling in 10 tumours. Age (r=-0.61, P=0.14) and AgNOR score (r=-0.58, P=0.17) had moderate, but non-significant, negative associations with survival. PCNA (r=-0.32, P=0.47), Ki67 (r=-0.22, P=0.64) and c-Kit immunolabelling was not associated with survival. The subcutaneous variant of canine mast cell tumour is distinct in having features of intermediate histological grade and extended mean survival times, suggesting a slightly better long-term prognosis than for higher grade dermal variants. Expression of nuclear proliferation markers is not associated with outcome.


Subject(s)
Mastocytosis, Cutaneous/diagnosis , Mastocytosis, Cutaneous/veterinary , Skin Neoplasms/diagnosis , Skin Neoplasms/veterinary , Animals , Dogs , Immunohistochemistry , Ki-67 Antigen/metabolism , Mastocytosis, Cutaneous/metabolism , Neoplasm Staging , Prognosis , Proliferating Cell Nuclear Antigen/metabolism , Skin Neoplasms/metabolism
6.
Theriogenology ; 67(9): 1512-7, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17459465

ABSTRACT

Various surgical techniques to correct urovagina in cows describe creating a mucosal extension from the urethral orifice to the labia; however, a fistula often forms in the mucosal extension. The objective of the present study was to determine if the incidence of fistula formation could be decreased by covering transposed submucosal tissue on the dorsal aspect of the urethral extension with a mucosal graft. Cows in both the control group (19) and the experimental group (19) received a modified McKinnon technique of urethral extension; cows in the experimental group also had a sheet of mucosa, obtained from the dorsal aspect of the vestibule, grafted to submucosa exposed during creation of the urethral extension. During histological examination of the biopsy of the graft and its recipient site (harvested 1 week after surgery), neither inosculation nor revascularization of the graft was evident in any sample. Fourteen of 19 (74%) cows in the control group and 10 of 19 (53%) cows in the experimental group developed a fistula in the extension (P=0.18). We concluded that application of a mucosal graft to the subcutaneous tissue exposed to the vestibule using the McKinnon technique of creating a urethral extension was of little or no benefit in preventing the formation of a fistula in the extension. Furthermore, during evaluation of the extensions, digital palpation alone was often insufficient for detection of a fistula.


Subject(s)
Cattle Diseases/surgery , Urethra/surgery , Urination Disorders/veterinary , Vaginal Diseases/veterinary , Animals , Cattle , Female , Mucous Membrane/transplantation , Treatment Outcome , Urinary Fistula/veterinary , Urination Disorders/surgery , Vaginal Diseases/surgery
7.
Equine Vet J ; 48(6): 727-731, 2016 Nov.
Article in English | MEDLINE | ID: mdl-26537825

ABSTRACT

REASONS FOR PERFORMING STUDY: Crib-biting is a common oral stereotypy. Although most treatments involve prevention, the efficacy of various anti-crib devices, including surgically implanted gingival rings, has thus far not been empirically tested. OBJECTIVES: Demonstrate the effect that 2 anti-crib collars, muzzle and gingival rings have on crib-biting, other maintenance behaviours, and cortisol levels in established crib-biting horses. STUDY DESIGN: Randomised, crossover clinical trial. METHODS: In Experiment I, 2 anti-crib collars and a muzzle were used on 8 established crib-biting horses; horses wore each of 3 devices for 7 days, with a 7-day device-free period between treatments. Horses were video recorded for 24 h at least 3 times each week prior to any device placement, and always the day after a device was removed. In Experiment II, gingival rings were used in 6 established crib-biting horses; horses were video recorded for 3 days prior to ring implantation and the day after surgery until the rings became ineffective. Plasma cortisol levels were assessed every day during Experiment II and on Days 1, 3 and 5 of each week during Experiment I. RESULTS: All devices significantly reduced crib-biting compared with control periods. There was no significant difference in crib-bite reduction amongst devices in Experiment I, or between pre-device periods and the first day the device was removed. The only increase in plasma cortisol occurred on the day of surgery in Experiment II. CONCLUSIONS: Common anti-crib devices are effective in reducing crib-biting and significant distress was not evident from our findings. We did not find a post inhibitory rebound effect. Surgical rings were successful only temporarily and implantation was probably painful to the horses. Because stereotypies involve suboptimal environmental conditions, efforts should be made to improve husbandry factors previously shown to contribute to crib-biting, and research into decreasing horses' motivation to crib-bite should continue.


Subject(s)
Behavior, Animal , Horse Diseases/prevention & control , Horses/physiology , Stereotyped Behavior , Animals
8.
Exp Hematol ; 24(1): 11-7, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8536786

ABSTRACT

Hematopoiesis is regulated by complex interactions of hematopoietic growth factors known as colony-stimulating factors and interleukins. We used sensitive bioassays to quantitate serum granulocyte colony-stimulating factor (G-CSF) and interleukin-1 (IL-1) concentrations in normal and tumor-bearing dogs following administration of myelosuppressive chemotherapy (vincristine, doxorubicin, cyclophosphamide). Serum G-CSF and IL-1 increased during the neutrophil nadir in 13 of the 16 dogs. Serum G-CSF concentrations were significantly increased in normal and in tumor-bearing dogs on neutropenic compared to non-neutropenic days. Serum IL-1 concentrations increased significantly on neutropenic days in normal dogs but not in tumor-bearing dogs. A marked neutrophilia was observed in normal dogs, but not in tumor-bearing dogs, following the increases in serum G-CSF and IL-1 concentrations (days 7, 8, and 9, p < 0.05). Normal dogs produced significantly more G-CSF on neutropenic days compared to dogs with lymphoma. On non-neutropenic days, serum IL-1 concentrations were significantly increased in dogs with lymphoma and in dogs with nonlymphoid malignancies compared to normal dogs. These results suggest an important role for G-CSF and IL-1 in hematopoietic recovery after chemotherapy-induced myelosuppression and document an altered hematopoietic regulation in animals with malignancy compared to normal subjects.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Dog Diseases/blood , Granulocyte Colony-Stimulating Factor/blood , Interleukin-1/blood , Neoplasms/veterinary , Neutropenia/blood , Animals , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cyclophosphamide/administration & dosage , Dog Diseases/drug therapy , Dogs , Doxorubicin/administration & dosage , Female , Hemangiosarcoma/blood , Hemangiosarcoma/drug therapy , Hemangiosarcoma/veterinary , Lymphoma/blood , Lymphoma/drug therapy , Lymphoma/veterinary , Male , Neoplasms/blood , Neoplasms/drug therapy , Neutropenia/chemically induced , Sarcoma, Synovial/blood , Sarcoma, Synovial/drug therapy , Sarcoma, Synovial/veterinary , Vincristine/administration & dosage
9.
Vet Comp Oncol ; 13(3): 314-21, 2015 Sep.
Article in English | MEDLINE | ID: mdl-23845124

ABSTRACT

Masitinib mesylate is a tyrosine kinase inhibitor approved for the treatment of gross, non-metastatic grade II and III canine mast cell tumours (MCTs). This study evaluated the use of masitinib as a frontline and rescue agent for metastatic and non-metastatic canine MCTs. Identification of toxicities and prognostic factors in these dogs was of secondary interest. Twenty-six dogs were included in this study. The overall response rate to masitinib was 50%. The median survival time for dogs that responded to masitinib was 630 days versus 137 days for dogs that did not respond (P = 0.0033). Toxicity was recorded in 61.5% of treated dogs, but the majority of adverse events were mild and self-limiting. Response to masitinib, not tumour grade, stage or location, was the most significant prognostic factor for survival in dogs with MCTs.


Subject(s)
Dog Diseases/drug therapy , Mastocytosis, Cutaneous/veterinary , Protein Kinase Inhibitors/therapeutic use , Skin Neoplasms/veterinary , Thiazoles/therapeutic use , Animals , Benzamides , Disease-Free Survival , Dogs , Female , Kaplan-Meier Estimate , Male , Mastocytosis, Cutaneous/drug therapy , Neoplasm Staging , Piperidines , Protein Kinase Inhibitors/pharmacology , Pyridines , Schools, Veterinary , Skin Neoplasms/drug therapy , Tennessee , Thiazoles/pharmacology
10.
Vet Comp Oncol ; 13(1): 20-7, 2015 Mar.
Article in English | MEDLINE | ID: mdl-23331512

ABSTRACT

We hypothesized that neutrophil function in tumour-bearing dogs is negatively impacted by chemotherapy. Flow cytometric techniques were used to assess neutrophil oxidative burst and phagocytic activities at baseline, 7 and 21 days after induction chemotherapy in 20 dogs with lymphoma. Dogs had a lower percentage of neutrophils exhibiting oxidative burst activity after stimulation with Escherichia coli (day 7; P = 0.009) and phorbol 12-myristate 13-acetate (PMA) (days 7 and 21; P = 0.0003 and P = 0.01, respectively), compared with healthy controls. From day 0 to 7, the percentage of neutrophils exhibiting oxidative burst activity decreased after stimulation with E. coli (P = 0.016) and PMA (P = 0.0006). Induction chemotherapy suppresses the percentage of neutrophils capable of oxidative burst in dogs with lymphoma, with improvement in phagocytic activity over time (P = 0.03). The impact of neutrophil dysfunction on incidence and severity of sepsis in dogs receiving chemotherapy should be investigated.


Subject(s)
Dog Diseases/drug therapy , Neoplasms/veterinary , Neutropenia/veterinary , Neutrophils/drug effects , Animals , Dog Diseases/immunology , Dogs , Neoplasms/drug therapy , Neoplasms/immunology , Neutropenia/chemically induced , Neutrophils/physiology , Respiratory Burst
11.
J Vet Intern Med ; 29(1): 193-9, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25411029

ABSTRACT

BACKGROUND: Atypical hyperadrenocorticism (AHAC) is considered when dogs have clinical signs of hypercortisolemia with normal hyperadrenocorticism screening tests. HYPOTHESIS/OBJECTIVES: To compare cortisol concentrations and adrenal gland size among dogs with pituitary-dependent hyperadrenocorticism (PDH), atypical hyperadrenocorticism (AHAC), and healthy controls. ANIMALS: Ten healthy dogs, 7 dogs with PDH, and 8 dogs with AHAC. METHOD: Dogs were prospectively enrolled between November 2011 and January 2013. Dogs were diagnosed with PDH or AHAC based on clinical signs and positive screening test results (PDH) or abnormal extended adrenal hormone panel results (AHAC). Transverse adrenal gland measurements were obtained by abdominal ultrasound. Hourly mean cortisol (9 samplings), sum of hourly cortisol measurements and adrenal gland sizes were compared among the 3 groups. RESULTS: Hourly (control, 1.4 ± 0.6 µg/dL; AHAC, 2.9 ± 1.3; PDH, 4.3 ± 1.5) (mean, SD) and sum (control, 11.3 ± 3.3; AHAC, 23.2 ± 7.7; PDH, 34.7 ± 9.9) cortisol concentrations differed significantly between the controls and AHAC (P < .01) and PDH (P < .01) groups. Hourly (P < .01) but not sum (P = .27) cortisol concentrations differed between AHAC and PDH dogs. Average transverse adrenal gland diameter of control dogs (5.3 ± 1.2 mm) was significantly less than dogs with PDH (6.4 ± 1.4; P = .02) and AHAC (7.2 ± 1.5; P < .01); adrenal gland diameter did not differ (P = .18) between dogs with AHAC and PDH. CONCLUSIONS AND CLINICAL IMPORTANCE: Serum cortisol concentrations in dogs with AHAC were increased compared to controls but less than dogs with PDH, while adrenal gland diameter was similar between dogs with AHAC and PDH. These findings suggest cortisol excess could contribute to the pathophysiology of AHAC.


Subject(s)
Adrenocortical Hyperfunction/veterinary , Dog Diseases/blood , Hydrocortisone/blood , Adrenal Glands/pathology , Adrenocortical Hyperfunction/classification , Adrenocortical Hyperfunction/pathology , Animals , Dog Diseases/pathology , Dogs , Female , Male
12.
J Vet Diagn Invest ; 12(5): 453-5, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11021434

ABSTRACT

Twenty-two lactating Holstein cattle in Tennessee had clinical signs of intoxication with preformed Clostridium botulinum toxin. These signs included weakness, paralysis of the tongue and chest muscles, abdominal breathing, and, in 11 of the 22 cows, death. Differential diagnoses included hypocalcemia, hypomagnesemia, carbohydrate overload, and several toxicoses including mycotoxin, lead, nitrate, organophosphate, atropine or atropine-like alkaloid, and botulism. A diagnosis of botulism by the ingestion of preformed C. botulinum type B toxin was made by eliminating these other diseases, by finding C. botulinum type B spores in 3 bales of round bale barley haylage fed to these cattle, and by isolating preformed type B toxin from 1 of the 3 bales. Confirmation of the toxin type was made by demonstrating mouse lethality by intraperitoneal injection of specimen extracts with neutralization by C. botulinum type B antitoxin. The haylage, harvested green and encased in black plastic bags to facilitate fermentation, was presumably contaminated by the botulinum toxin when fermentation failed to produce enough acid to lower the pH to 4.5, the pH below which C. botulinum growth is inhibited. Farmers and ranchers who use round hay balers to produce haylage should be alert to this potential problem.


Subject(s)
Animal Feed/microbiology , Botulinum Toxins/toxicity , Botulism/veterinary , Cattle Diseases/microbiology , Clostridium botulinum , Hordeum/microbiology , Animal Husbandry , Animals , Botulism/microbiology , Botulism/mortality , Cattle , Cattle Diseases/mortality , Diagnosis, Differential , Disease Outbreaks/veterinary , Fatal Outcome , Female , Fermentation , Food Contamination , Hydrogen-Ion Concentration
13.
Vet Parasitol ; 42(1-2): 111-22, 1992 Apr.
Article in English | MEDLINE | ID: mdl-1615622

ABSTRACT

A sample of 126 sheep producers in Tennessee was randomly selected from the members of a statewide organization of sheep producers. Data about the participants' farms, sheep, parasite control practices and sources of information regarding ovine parasite control were obtained by a telephone survey. The response rate was 99%. The typical respondent kept 20 lambs, 20 ewes and 2 rams on three pastures totalling 20 acres. In order of decreasing frequency, anthelmintics were given according to a regular schedule, to coincide with breeding management procedures, or to treat clinical signs of parasitism. Proportions of producers deworming the various classes of sheep zero, one, two, three, four or more than four times annually were as follows: lambs--3, 28, 40, 16, 9 and 8%, respectively; ewes--3, 8, 20, 16, 34 and 22%, respectively; rams--1, 9, 19, 15, 38 and 19%, respectively. The majority of respondents planned to deworm lambs (89%) and ewes (82%) the same number of times in the following year. Of the producers who dewormed sheep two or more times during 1989, 39-49% (ranges include different proportions for lambs, ewes and rams) used the same anthelmintic exclusively, and 51-61% used two or more drug classes. Of the owners using a single anthelmintic exclusively, most (39-66%) used ivermectin, followed by levamisole (19-33%) and benzimidazoles (13-24%). One hundred and three of 124 (83%) producers intended to use the same anthelmintics in the future. Sixty-four of 124 (52%) producers had discontinued using at least one ovine anthelmintic. The most common reasons for discontinuance were dissatisfaction with the clinical response after treatment and inconvenience of administration. Sheep-oriented publications, other sheep producers and veterinarians were considered the most important sources of information about deworming programs and choice of anthelmintics.


Subject(s)
Anthelmintics/therapeutic use , Parasitic Diseases, Animal , Sheep Diseases/prevention & control , Animals , Demography , Interviews as Topic , Parasitic Diseases/prevention & control , Sheep , Surveys and Questionnaires , Telephone , Tennessee
14.
Domest Anim Endocrinol ; 24(1): 43-57, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12450624

ABSTRACT

The purpose of this study was to determine steroid hormone concentration profiles in healthy intact and neutered male and female dogs. Seventeen intact female dogs, 20 intact male dogs, 30 spayed female dogs, and 30 castrated male dogs were used in this study. Serum samples were collected before and 1h after cosyntropin administration, and serum concentrations were determined for cortisol, progesterone, 17-OH progesterone (17-OHP), dehydroepiandrosterone sulfate (DHEAS), androstenedione, testosterone, and estradiol. Intact male dogs had greater concentrations of DHEAS, androstenedione, and testosterone. Intact female dogs had greater concentrations of progesterone. There was no significant difference in estradiol concentration among the four groups. Intact male dogs had lower concentrations of cortisol post-stimulation. DHEAS and testosterone did not increase in response to ACTH in intact males, and estradiol concentrations did not increase in response to ACTH in any group. Results from this study will enhance interpretation of suspected adrenal and/or gonadal disorders of dogs. Because estradiol concentrations were similar in all groups of dogs, measuring estradiol may not be a useful diagnostic test. Cortisol concentrations for intact male dogs with hyperadrenocorticism may be lower than those of female or neutered dogs.


Subject(s)
Cosyntropin/administration & dosage , Dogs/blood , Hormones/blood , Orchiectomy , Ovariectomy , 17-alpha-Hydroxyprogesterone/blood , Aging , Androstenedione/blood , Animals , Dehydroepiandrosterone Sulfate/blood , Estradiol/blood , Female , Hydrocortisone/blood , Male , Progesterone/blood , Testosterone/blood
15.
Equine Vet J ; 29(5): 370-3, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9306063

ABSTRACT

This study determined the effects of epidurally administered morphine, ketamine and butorphanol on halothane minimum alveolar concentration (MAC) in ponies. Seven ponies were anaesthetised with thiopentone and succinylcholine, intubated and anaesthesia maintained with halothane. Ventilation was controlled and blood pressure was maintained within normal limits. Following the determination of baseline halothane MAC for the pelvic and thoracic limbs the ponies were given morphine (0.1 mg/kg bwt), ketamine (0.8 or 1.2 mg/kg bwt), butorphanol (0.05 mg/kg bwt) or saline, epidurally, to a final volume of 0.15 ml/kg bwt. The halothane MAC for the pelvic and thoracic limbs was redetermined following each treatment. The baseline halothane MAC for the control group was mean +/- s.e. 0.85 +/- 0.02% and no significant change occurred after saline administration. Morphine significantly (P = 0.002) decreased MAC from, mean +/- s.e. 0.90 +/- 0.05% to 0.77 +/- 0.06% in the pelvic limb. Ketamine significantly decreased MAC in the pelvic limb from mean +/- s.e. 0.86 +/- 0.06% to 0.71 +/- 0.04%, and 0.82 +/- 0.03% to 0.71 +/- 0.02%, for the low (P = 0.008) and high dose (P = 0.001), respectively. No significant change in MAC occurred following butorphanol. No treatment reduced halothane MAC for the thoracic limb.


Subject(s)
Analgesics/pharmacology , Anesthetics, Inhalation/metabolism , Butorphanol/pharmacology , Halothane/metabolism , Horses/metabolism , Ketamine/pharmacology , Morphine/pharmacology , Pulmonary Alveoli/chemistry , Analgesics/administration & dosage , Anesthetics, Dissociative/administration & dosage , Anesthetics, Dissociative/pharmacology , Animals , Blood Pressure/drug effects , Blood Pressure/physiology , Butorphanol/administration & dosage , Dose-Response Relationship, Drug , Drug Interactions , Horses/physiology , Injections, Epidural/methods , Injections, Epidural/veterinary , Ketamine/administration & dosage , Male , Morphine/administration & dosage , Pulmonary Alveoli/metabolism , Pulmonary Ventilation/drug effects , Pulmonary Ventilation/physiology , Random Allocation
16.
Equine Vet J ; 29(5): 374-6, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9306064

ABSTRACT

The effect of i.v. acepromazine (0.05 mg/kg bwt), butorphanol (0.05 mg/kg bwt) and a combination of acepromazine and butorphanol on halothane minimum alveolar concentration (MAC) was determined in 7 mixed-breed ponies. Ventilation was controlled, and blood pressure and temperature were maintained within normal limits. Following the determination of baseline MAC, treatments were administered to each pony in a random manner. The control treatment was normal saline. The baseline halothane dMAC for the control group was 0.91 +/- 0.04%, and no significant change occurred after saline administration. Acepromazine decreased (P = 0.0001) the halothane MAC from mean +/- s.e. 0.92 +/- 0.02% to 0.58 +/- 0.04%, and the combination of acepromazine and butorphanol, decreased (P = 0.003) halothane MAC, from mean +/- s.e. 0.95 +/- 0.04% to 0.59 +/- 0.06%. This represents a decrease of 36.9 and 37.8%, respectively. However, the difference between these 2 treatments was not significant. Butorphanol did not significantly change the mean group value for MAC; nevertheless, 3 ponies had an increase, one a decrease, while the MAC did not change in the remaining 3 ponies following butorphanol treatment.


Subject(s)
Acepromazine/pharmacology , Analgesics, Opioid/pharmacology , Anesthetics, Inhalation/metabolism , Butorphanol/pharmacology , Dopamine Antagonists/pharmacology , Halothane/metabolism , Horses/metabolism , Pulmonary Alveoli/metabolism , Acepromazine/administration & dosage , Analgesics, Opioid/administration & dosage , Animals , Blood Pressure/drug effects , Blood Pressure/physiology , Body Temperature/drug effects , Body Temperature/physiology , Butorphanol/administration & dosage , Dopamine Antagonists/administration & dosage , Drug Interactions , Female , Horses/physiology , Injections, Intravenous/methods , Injections, Intravenous/veterinary , Male , Pulmonary Ventilation/drug effects , Pulmonary Ventilation/physiology , Random Allocation
17.
Equine Vet J ; 35(5): 472-5, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12875325

ABSTRACT

REASONS FOR PERFORMING STUDY: Endotoxaemia causes a disruption of gastrointestinal motility in the horse but there is no information on its effects on gastric secretion. Lipopolysaccharide (LPS) administration is known to affect gastric secretion in other species. HYPOTHESIS: That LPS, a toxic component of Gram-negative bacteria, would reduce gastric acid secretion and that pretreatment with phenylbutazone (PBZ) would block the effects of LPS. METHODS: The effects of LPS and PBZ on gastric contents were investigated in fasted, mature horses, with permanent gastric cannulae. Horses were pretreated with either saline or PBZ 15 mins before a 60 min infusion of either LPS or saline. Gastric contents were collected at 15 min intervals for 3 h, beginning 15 mins after the start of the LPS or saline infusion. RESULTS: Lipopolysaccharide significantly decreased gastric acid output, [K+] and potassium output and increased [Na+] and sodium output. Phenylbutazone did not affect basal gastric acid secretion but decreased LPS-induced changes in the secreted volume, [Na+] and sodium output. CONCLUSIONS: This study provides evidence that LPS affects gastric acid secretion in the horse and that these LPS-induced changes are mediated, in part, by prostaglandins. POTENTIAL RELEVANCE: Lipopolysaccharide administration can induce changes in the composition of gastric contents in the horse but further work is needed to determine the source of these changes.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Gastric Acid/metabolism , Gastrointestinal Contents/drug effects , Horses/physiology , Lipopolysaccharides/antagonists & inhibitors , Phenylbutazone/pharmacology , Animals , Female , Gastrointestinal Contents/chemistry , Hydrogen-Ion Concentration , Lipopolysaccharides/pharmacology , Potassium/metabolism , Random Allocation , Sodium/metabolism
18.
J Vet Intern Med ; 10(6): 365-71, 1996.
Article in English | MEDLINE | ID: mdl-8947868

ABSTRACT

One hundred twelve client-owned dogs with blastomycosis were treated with itraconazole, 5 or 10 mg/kg/d. The first group of 70 dogs treated in 1987 and 1988 received 10 mg/kg/d (group 1), and the second group of 42 dogs treated after October 1988 received 5 mg/kg/d (group 2). Even though the groups were treated at different times, the dogs were similar in age and gender distribution, number of sites involved, and percent and severity of pulmonary involvement. The proportion of dogs cured with a 60-day course of itraconazole was similar for both groups (53.6% versus 54.3%) and for a second historical control group treated with amphotericin B (57%); the recurrence rate was also similar, 20%, 21.4%, and 20%, respectively. Dogs treated with itraconazole had similar mortality rates (25.7% at 5 mg/kg/d; 25% at 10 mg/kg/day) to those treated with amphotericin B (23%). Seventeen of the 23 dogs that died (74%), did so during the first week of treatment; these early deaths were usually attributed to respiratory failure. The only site of infection that was significantly associated with failure (death or recurrence) was the brain. There was a marked difference in survival times between dogs without lung disease or with mild lung disease compared with dogs with moderate or severe lung disease. Serum itraconazole concentrations reached steady state by 14 days of treatment. Dogs receiving 5 mg/kg/d of itraconazole (group 2) had mean serum concentrations of 3.55 +/- 2.81 mg/mL (range, 0.67 to 10.8 micrograms/mL), whereas dogs receiving 10 micrograms/kg/d (group 1) had mean concentrations of 13.46 +/- 8.49 micrograms/mL (range, 1.8 to 28 micrograms/mL) (P < or = .001). There was no association between cure and serum itraconazole concentrations. Dogs in group 1 had significantly more adverse effects than dogs in group 2 (P = .046). Anorexia was the most common adverse effect, occurring in 14.9% of dogs in group 1. Only 8% of dogs in group 2 had adverse effects. Serum concentrations of itraconazole were positively correlated with serum alkaline phosphatase and alanine aminotransferase activities. Our findings indicate that itraconazole administered at a dose of 5 mg/kg/d is the drug of choice for blastomycosis in dogs.


Subject(s)
Antifungal Agents/therapeutic use , Blastomycosis/veterinary , Dog Diseases/drug therapy , Itraconazole/therapeutic use , Alanine Transaminase/blood , Alkaline Phosphatase/blood , Animals , Antifungal Agents/adverse effects , Antifungal Agents/blood , Blastomycosis/drug therapy , Blastomycosis/mortality , Brain Diseases/etiology , Brain Diseases/microbiology , Brain Diseases/veterinary , Dog Diseases/blood , Dog Diseases/mortality , Dogs , Dose-Response Relationship, Drug , Female , Itraconazole/adverse effects , Itraconazole/blood , Liver/enzymology , Lung Diseases/etiology , Lung Diseases/microbiology , Lung Diseases/veterinary , Male , Skin Diseases/etiology , Skin Diseases/microbiology , Skin Diseases/veterinary
19.
J Anim Sci ; 78(4): 1029-35, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10784195

ABSTRACT

The objective of the current study was to delineate changes that occur in serum analytes and blood cellular elements in cattle that graze endophyte-infested (Neotyphodium coenophialum) tall fescue. Tall fescue is grown on more than 35 million acres (14.2 million ha) of pasture in the United States, and three-fourths of the pastures are infected with the endophyte at a 60% or greater level. Tall fescue toxicosis caused by endophyte-produced ergot alkaloids continues to be the most important grass-related disease in the United States, in terms of economic loss to animal producers. However, the agronomic attributes of tall fescue make it an attractive forage species because of its ability to withstand cool temperatures, drought, poor soil conditions, and intensive defoliation from herbivore species, including insects. Tall fescue toxicosis is a complex disease and the need exists to understand the mechanisms of the toxic effects in order to institute effective, prophylactic control measures. Our group previously reported changes that occur in serum biochemical analytes of cattle that graze endophyte-infected tall fescue. An additional year's worth of data have been added, strengthening and corroborating these data. Consistent and significant changes associated with tall fescue toxicosis during the 3-yr study included decreased serum concentrations of cholesterol, globulin (increased albumin/globulin ratio), prolactin, total protein, and copper. The activity of alanine aminotransferase was decreased in serum, whereas an increase in serum concentrations of creatinine and total bilirubin occurred. The present report also documents comparative hemograms of cattle that grazed endophyte-infected or endophyte-free tall fescue over a prolonged period. The mean erythrocyte counts were increased in cattle that grazed endophyte-infected tall fescue, whereas mean corpuscular hemoglobin and mean corpuscular volume were decreased, as were mean eosinophil counts. Thus, repeatable changes have been identified that occur in serum biochemical and blood cellular values of cattle grazing endophyte-infected tall fescue that will aid in understanding the pathogenesis of the disease. In addition, these consistently altered parameters can be used to assess the effectiveness of potential prophylactic treatments.


Subject(s)
Acremonium , Animal Feed/microbiology , Cattle/blood , Poaceae/microbiology , Animals , Enzyme-Linked Immunosorbent Assay/veterinary , Ergotism/blood , Ergotism/veterinary , Erythrocyte Indices , Hemoglobins/metabolism
20.
Am J Vet Res ; 53(9): 1617-21, 1992 Sep.
Article in English | MEDLINE | ID: mdl-1416365

ABSTRACT

End-tidal carbon dioxide tension (PetCO2) and arterial carbon dioxide tension (PaCO2) were determined and compared in isoflurane-anesthetized spontaneously breathing equine neonates. End-tidal carbon dioxide and PaCO2 values increased with respect to time. Difference between values of PetCO2 and PaCO2 increased over time. End-tidal carbon dioxide tension was useful to predict changes in and was more closely correlated with PaCO2 early in the anesthetic period (T less than or equal to 60 minutes). The dead space volume to tidal volume (Vd/Vt) ratio increased with respect to time, indicating increase in physiologic dead space in isoflurane-anesthetized foals. The data indicate that the increased difference between widening of the PetCO2 and PaCO2 values over time may have been attributable to hypoventilation and decreased pulmonary capillary perfusion of alveoli.


Subject(s)
Anesthesia, Inhalation/veterinary , Animals, Newborn/blood , Carbon Dioxide/blood , Horses/blood , Isoflurane , Animals , Blood Gas Analysis/veterinary , Blood Pressure , Heart Rate , Respiration , Tidal Volume
SELECTION OF CITATIONS
SEARCH DETAIL